Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

After a year of dwindling coffers and repeated layoff rounds, the Southern California biotech firm Viracta Therapeutics has finally reached the end of its road. The company is laying off every ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

The Fast Track designation accelerates troculeucel’s path to U.S. FDA submission for the treatment of patients with moderate Alzheimer’s ...

In interviews, the companies claim that their undisclosed efforts use newer technologies that are really dreaming up drugs from scratch. A federal judge will soon decide whether to dismiss a ...

In addition, 80 Acres Farms announced it acquired Plantae Bioscience, an Israeli biotechnology company. "Our ability to raise capital in today's market speaks to the confidence investors have in ...

IXP, a life sciences-focused venture capital (VC) firm backed by JV Ventures, launched its first fund, IXP Lifesciences Catalyst Fund, to invest in early-stage biotech startups. It has a corpus of ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The reimagined Avid website captures the company’s elevated brand through the tagline, “Discover the Avid effect.™”, helping educate visitors on the differentiation that positions the company as one ...

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...